Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

uniQure N.V. - Ordinary Shares (NQ:QURE)

21.71 -0.66 (-2.95%)

Streaming Delayed Price Updated: 9:56 AM EST, Feb 13, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	263,660
Open	22.37
Bid (Size)	21.66 (100)
Ask (Size)	21.89 (900)
Prev. Close	22.37
Today's Range	21.31 - 22.60
52wk Range	7.760 - 71.50
Shares Outstanding	54,865,673
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ATTENTION NASDAQ: QURE INVESTORS: Contact Berger Montague About an uniQure N.V. Class Action Lawsuit

Today 9:13 EST

From Berger Montague

Via GlobeNewswire

uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE

February 12, 2026

From SkyMedia, LLC

Via GlobeNewswire

Performance

YTD	-7.2%	-7.2%
1 Month	+1.0%	+1.0%
3 Month	-28.4%	-28.4%
6 Month	+37.6%	+37.6%
1 Year	+63.2%	+63.2%

More News

UNIQURE N.V. (QURE) INVESTOR ALERT Investors With Large Losses in uniQure N.V. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

February 12, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

uniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – QURE

February 12, 2026

From DJS Law Group

Via Business Wire

QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm

February 11, 2026

From The Schall Law Firm

Via Business Wire

INVESTOR ALERT: Securities Class Action Filed Against uniQURE N.V. – Investors Encouraged to Contact Kirby McInerney LLP

February 11, 2026

From Kirby McInerney LLP

Via Business Wire

QURE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026

February 11, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

Rosen Law Firm Urges uniQure N.V. (NASDAQ: QURE) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

February 11, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

February 11, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the uniQure N.V. Securities Class Action Lawsuit

February 10, 2026

From Robbins LLP

Via Business Wire

UNIQURE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against uniQure N.V. and Encourages Investors to Contact the Firm

February 10, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

uniQure N.V. (QURE) Investors: Kessler Topaz Meltzer & Check, LLP Announces That the Firm Has Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. and Encourages Investors to Contact the Firm

February 10, 2026

From Kessler Topaz Meltzer & Check, LLP

Via Business Wire

uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

February 06, 2026

From uniQure Inc.

Via GlobeNewswire

QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

January 24, 2026

Via NewMediaWire

QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

January 24, 2026

Via TheNewswire.com

UNIQURE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating uniQure N.V. on Behalf of uniQure Stockholders and Encourages Investors to Contact the Firm

January 22, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market

January 22, 2026

Via MarketMinute

QURE Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

January 19, 2026

Via TheNewswire.com

QURE Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

January 19, 2026

Via NewMediaWire

uniQure N.V. Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

January 10, 2026

Via NewMediaWire

uniQure N.V. Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

January 09, 2026

Via NewMediaWire

uniQure N.V. Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

January 09, 2026

Via TheNewswire.com

uniQure Stock Jumps After Scheduling FDA Type A Meeting For AMT‑130 Approval Pathway ↗

January 09, 2026

Via Benzinga

uniQure Announces Type A Meeting Scheduled with FDA

January 09, 2026

From uniQure Inc.

Via GlobeNewswire

QURE Investigation: Investors Encouraged to Contact Kirby McInerney LLP

January 05, 2026

From Kirby McInerney LLP

Via Business Wire

Frequently Asked Questions

Is uniQure N.V. - Ordinary Shares publicly traded?

Yes, uniQure N.V. - Ordinary Shares is publicly traded.

What exchange does uniQure N.V. - Ordinary Shares trade on?

uniQure N.V. - Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for uniQure N.V. - Ordinary Shares?

The ticker symbol for uniQure N.V. - Ordinary Shares is QURE on the Nasdaq Stock Market

What is the current price of uniQure N.V. - Ordinary Shares?

The current price of uniQure N.V. - Ordinary Shares is 21.71

When was uniQure N.V. - Ordinary Shares last traded?

The last trade of uniQure N.V. - Ordinary Shares was at 02/13/26 09:56 AM ET

What is the market capitalization of uniQure N.V. - Ordinary Shares?

The market capitalization of uniQure N.V. - Ordinary Shares is 1.19B

How many shares of uniQure N.V. - Ordinary Shares are outstanding?

uniQure N.V. - Ordinary Shares has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.